Dallas, TX -- (SBWIRE) -- 02/04/2015 -- The report "Thrombocythaemia Myelofibrosis – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Thrombocythaemia Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombocythaemia Myelofibrosis and special features on late-stage and discontinued projects.

Complete Report is Available
http://www.rnrmarketresearch.com/thrombocythaemia-myelofibrosis-pipeline-review-h1-2015-market-report.html

It also reviews key players involved in the therapeutic development for Thrombocythaemia Myelofibrosis and special features on late-stage and discontinued projects. Companies discussed in this Thrombocythaemia Myelofibrosis Pipeline Review H1 2015 report include Gilead Sciences, Inc., Incyte Corporation, MEI Pharma, Inc., Nippon Shinyaku Co., Ltd., Novartis AG.

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269605 . (This is a premium report priced at US$2000 for a single user License.)

Table of Contents

List of Tables

Number of Products under Development for Thrombocythaemia Myelofibrosis, H1 2015 7
Number of Products under Development for Thrombocythaemia Myelofibrosis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Thrombocythaemia Myelofibrosis - Pipeline by Gilead Sciences, Inc., H1 2015 13
Thrombocythaemia Myelofibrosis - Pipeline by Incyte Corporation, H1 2015 14
Thrombocythaemia Myelofibrosis - Pipeline by MEI Pharma, Inc., H1 2015 15
Thrombocythaemia Myelofibrosis - Pipeline by Nippon Shinyaku Co., Ltd., H1 2015 16
Thrombocythaemia Myelofibrosis - Pipeline by Novartis AG, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 26
Thrombocythaemia Myelofibrosis Therapeutics - Recent Pipeline Updates, H1 2015 47
Thrombocythaemia Myelofibrosis - Discontinued Products, H1 2015 58

List of Figures

Number of Products under Development for Thrombocythaemia Myelofibrosis, H1 2015 7
Number of Products under Development for Thrombocythaemia Myelofibrosis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Clinical Stage Development, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 19
Number of Products by Stage and Top 10 Targets, H1 2015 19
Number of Products by Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 23
Number of Products by Top 10 Molecule Types, H1 2015 25
Number of Products by Stage and Top 10 Molecule Types, H1 2015 25

Explore more reports on Cancer Drugs industry
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/cancer-drugs

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.